Brief: Valeo Pharma Enters Into Canadian Commercial Services Agreement With Veru For Sabizabulin In Hospitalized Adult Patients With Covid-19

Valeo Pharma

14/09/2022 12:10

Sept 14 (Reuters) - Valeo Pharma Inc  VPH.TO :
    * VALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES
AGREEMENT
WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH
COVID-19 AT HIGH RISK FOR ACUTE RESPIRATORY DISTRESS SYNDROME
(ARDS)
    * VALEO PHARMA INC - VERU WILL BE REQUESTING THAT HEALTH
CANADA
UTILIZE ACCESS CONSORTIUM REGULATORY PATHWAY
    * ALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES
AGREEMENT
WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH
COVID-19 AT RISK FOR ARDS

Source text for Eikon:  ID:nCNWXXCNHa 
Further company coverage:  VPH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))